Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

585 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Agreement among movement disorder specialists on the clinical diagnosis of essential tremor.
Chouinard S, Louis ED, Fahn S. Chouinard S, et al. Mov Disord. 1997 Nov;12(6):973-6. doi: 10.1002/mds.870120621. Mov Disord. 1997. PMID: 9399223
With regard to exclusion criteria, there was some consensus in terms of the presence of Parkinson's disease, dystonia, history of hyperthyroidism or concurrent use of tremor-inducing medications, and cerebellar signs. ...
With regard to exclusion criteria, there was some consensus in terms of the presence of Parkinson's disease, dystonia, history of hyp …
Reliability of a new scale for essential tremor.
Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, Watts R, Zesiewicz T. Elble R, et al. Mov Disord. 2012 Oct;27(12):1567-9. doi: 10.1002/mds.25162. Epub 2012 Oct 2. Mov Disord. 2012. PMID: 23032792 Free PMC article.
Video Review of Baseline Performance on Global Ratings in a Double-Blind Placebo Surgery Trial.
McRae C, Caspari J, Russell D, Ellgring H, Bezzant C, Greene P, Fahn S. McRae C, et al. Among authors: fahn s. Mov Disord Clin Pract. 2018 Oct 4;5(6):597-602. doi: 10.1002/mdc3.12666. eCollection 2018 Nov-Dec. Mov Disord Clin Pract. 2018. PMID: 30637279 Free PMC article.
Essential Tips for Videotaping a Movement Disorders Patient Encounter.
Robakis D, Fahn S, Kestenbaum M. Robakis D, et al. Mov Disord Clin Pract. 2015 Jun 30;2(4):365-368. doi: 10.1002/mdc3.12204. eCollection 2015 Dec. Mov Disord Clin Pract. 2015. PMID: 30838238 Free PMC article. No abstract available.
Stimulus Sensitive Foot Myoclonus: A Clue to Coeliac Disease.
Jesús S, Latorre A, Vinuela A, Fahn S, Bhatia KP, Balint B. Jesús S, et al. Among authors: fahn s. Mov Disord Clin Pract. 2019 Apr 4;6(4):320-323. doi: 10.1002/mdc3.12753. eCollection 2019 Apr. Mov Disord Clin Pract. 2019. PMID: 31061841 Free PMC article.
Basal Ganglia Gliosis in a Case of Rapid-Onset Dystonia-Parkinsonism (DYT12) with a Novel Mutation in ATPase 1A3 (ATP1A3).
Sampson JB, Michaeli TH, Wright BA, Goldman JE, Vonsattel JP, Fahn S. Sampson JB, et al. Mov Disord Clin Pract. 2016 May 19;3(6):618-620. doi: 10.1002/mdc3.12354. eCollection 2016 Nov-Dec. Mov Disord Clin Pract. 2016. PMID: 30838256 Free PMC article. No abstract available.
[No authors listed] [No authors listed] PMID: 30653722
Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102.
Isaacson SH, Fahn S, Pahwa R, Tanner CM, Espay AJ, Trenkwalder C, Adler CH, Patni R, Johnson R. Isaacson SH, et al. Mov Disord Clin Pract. 2018 Mar-Apr;5(2):183-190. doi: 10.1002/mdc3.12595. Epub 2018 Feb 23. Mov Disord Clin Pract. 2018. PMID: 29780852 Free PMC article.
BACKGROUND: ADS-5102 (amantadine) extended release capsules (GOCOVRI™) are a treatment for dyskinesia in patients with Parkinson's disease (PD). ...Study outcomes included safety and assessment of motor complications, as measured by the Movement Disorder Society Unified Pa …
BACKGROUND: ADS-5102 (amantadine) extended release capsules (GOCOVRI™) are a treatment for dyskinesia in patients with Parkinson's di …
Reply: dystonia after severe head injuries.
Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Albanese A, et al. Mov Disord. 2014 Apr;29(4):578-9. doi: 10.1002/mds.25861. Epub 2014 Mar 3. Mov Disord. 2014. PMID: 24590449 No abstract available.
585 results
Jump to page
Feedback